Key result
Warfarin use linked to high oral disease burden and ~67% need for mandibular prostheses.
Why the study?
The burden of oral diseases and self-reported periodontal disease in patients receiving oral anticoagulation therapy with warfarin needed to be described.
Cross-Sectional (n=158)
No
Patients on chronic warfarin therapy exhibit a high burden of oral disease, including significant tooth loss and a high need for prostheses, highlighting the need for integrated dental care in this population.
Answers are grounded in this paper and cite their sources.
Substantial oral disease burden seen in warfarin users; hypothesis-generating for integrated dental-cardiac care and needs prospective confirmation.
Aim: To describe the burden of oral diseases and of self-reported periodontal disease of patients under Oral Anticoagulation Therapy (OAT) with warfarin.Methods: A cross-sectional study was conducted. Validated questionnaires assessed self-re-ported periodontal disease and demographic variables. After calibration (Kappa > 0.80), an examiner evaluated dental caries and the need for dental prostheses. Statistical analysis involved proportions and measures of central tendency. Results: The sample consisted of 158 individuals, with a mean age of 58.8 years (SD = 12.1), of which 62.7% of the participants were women. The average DMFT (Decayed, Mis-sing, and Filled Teeth) index was 22.9 (SD = 7.6), with the missing component being the highest (Mean = 16.23). The use of maxillary prosthesis (53.2%) was higher than mandibu-lar (32.3%). The need for mandibular prosthesis reached 66.5%. The percentage of partici-pants that referred gum disease, tooth migration, and tooth mobility was 29.6%, 37.4%, and 30.4%, respectively.Conclusions: The burden of oral diseases among individuals undergoing OAT is worrisome.
No takes yet. Share an insight, caveat, or question.
Moreno-Drada et al. (2023) conducted a cross-sectional in Patients under Oral Anticoagulation Therapy (OAT) with warfarin (n=158). Oral Anticoagulation Therapy with warfarin was evaluated on DMFT (Decayed, Missing, and Filled Teeth) index. Patients undergoing oral anticoagulation therapy with warfarin exhibited a high burden of oral diseases, with an average DMFT index of 22.9 and a 66.5% need for mandibular prostheses.
Synapse has enriched 10 related papers. Consider them for comparative context: